Literature DB >> 17396061

Smoking-related morbidity and mortality in the cardiovascular setting.

William B White1.   

Abstract

It is estimated that during the 20th century, 100 million people died of tobacco-related illnesses worldwide. The outlook for the future is grim as this number is expected to increase 10-fold during the 21st century. Many of these deaths will occur in middle-aged adults and, while most tobacco-related deaths currently occur in men, female mortality is expected to increase markedly due to increased rates of smoking in women, especially in developing countries. The risk of coronary heart disease is strongly associated with smoking in both developed and undeveloped countries. In addition, other forms of tobacco exposure (chewing, inhalation through water, and secondhand smoke) have also been documented to be important causes of coronary disease worldwide. Fortunately, the news is not all bad. Recent large-scale studies show that much of the excess risk associated with smoking is attenuated 1 to 2 years after quitting, depending on the level of smoking during an individual's lifetime. These latest findings should stimulate efforts of health care workers to become more aggressive toward cessation of smoking in our practices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396061     DOI: 10.1111/j.1520-037x.2007.06050.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  20 in total

1.  Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice.

Authors:  M A Hassan Talukder; Wesley M Johnson; Saradhadevi Varadharaj; Jiarui Lian; Patrick N Kearns; Mohamed A El-Mahdy; Xiaoping Liu; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

2.  Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

Authors:  Jed E Rose; Frédérique M Behm; Tomas Drgon; Catherine Johnson; George R Uhl
Journal:  Mol Med       Date:  2010-03-17       Impact factor: 6.354

3.  Airway epithelial cell PPARγ modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice.

Authors:  Siva Kumar Solleti; Dawn M Simon; Sorachai Srisuma; Meltem C Arikan; Soumyaroop Bhattacharya; Tirumalai Rangasamy; Kaiser M Bijli; Arshad Rahman; Joseph T Crossno; Steven D Shapiro; Thomas J Mariani
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-29       Impact factor: 5.464

4.  Cigarette smoking and mortality risk in people with schizophrenia.

Authors:  Deanna L Kelly; Robert P McMahon; Heidi J Wehring; Fang Liu; Kristen M Mackowick; Douglas L Boggs; Kimberly R Warren; Stephanie Feldman; Joo-Cheol Shim; Raymond C Love; Lisa Dixon
Journal:  Schizophr Bull       Date:  2009-12-17       Impact factor: 9.306

5.  Effect of smoking on the accumulation of deficits, frailty and survival in older adults: a secondary analysis from the Canadian Study of Health and Aging.

Authors:  R E Hubbard; S D Searle; A Mitnitski; K Rockwood
Journal:  J Nutr Health Aging       Date:  2009-05       Impact factor: 4.075

6.  The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study.

Authors:  Sarah E Linke; Thomas Rutledge; B Delia Johnson; Marian B Olson; Vera Bittner; Carol E Cornell; Leslee J Shaw; Wafia Eteiba; Susmita Parashar; David S Sheps; Diane A Vido; Suresh Mulukutla; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2009-04       Impact factor: 2.681

7.  Allostatic load in parents of children with developmental disorders: moderating influence of positive affect.

Authors:  Jieun Song; Marsha R Mailick; Carol D Ryff; Christopher L Coe; Jan S Greenberg; Jinkuk Hong
Journal:  J Health Psychol       Date:  2013-01-08

8.  Estimating benefits of past, current, and future reductions in smoking rates using a comprehensive model with competing causes of death.

Authors:  Jeroen van Meijgaard; Jonathan E Fielding
Journal:  Prev Chronic Dis       Date:  2012-07-05       Impact factor: 2.830

9.  The Vital@Work Study. The systematic development of a lifestyle intervention to improve older workers' vitality and the design of a randomised controlled trial evaluating this intervention.

Authors:  Jorien E Strijk; Karin I Proper; Allard J van der Beek; Willem van Mechelen
Journal:  BMC Public Health       Date:  2009-11-10       Impact factor: 3.295

Review 10.  Treatment of prehypertension: lifestyle and/or medication.

Authors:  Scott R Collier; Michael J Landram
Journal:  Vasc Health Risk Manag       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.